About
Regina Hodits is a Managing Director at Angelini Ventures. She previously served as Managing Partner at Wellington Partners Life Sciences and led the European life sciences efforts of Atlas Venture, and earlier worked at Apax Partners and McKinsey. She studied chemical engineering in Vienna, holds a Ph.D. in biochemistry, and conducted post-doctoral research at the MRC in Cambridge, UK.
Contact· published on Regina's own website
Invests in
BiotechDigital HealthMedical Devices
Experience
- Angelini VenturesManaging Directorcurrent2025 — presentMunich, Germany
- Wellington Partners Life SciencesVenture Advisorcurrent2025 — presentMunich, Germany
- Wellington Partners Life SciencesManaging Partner2010 — 2025Munich, Germany
- INiTS | Vienna's High-Tech IncubatorChairperson of the Board - Pro-Bonocurrent2012 — presentVienna, Austria
- BioInnovation InstituteBoard Membercurrent2020 — presentCopenhagen, Denmark
- EIT Health GermanyMember of the Expert Council - Pro-Bono2019 — 2024
- BVK Bundesverband Deutscher KapitalbeteiligungsgesellschaftenSpokesperson of the Board of Directors2015 — 2020Berlin, Germany
- GSK GlaxoSmithKlineExternal Director Respiratory Therapeutic Area Board2008 — 2014London, UK
- Atlas VentureGeneral Partner- Life Sciences2004 — 2010Munich GER London UK
- Apax PartnersInvestment Manager2000 — 2004Munich, Germany
- McKinsey & CompanyEngagement Manager1997 — 2000Vienna AUT / London UK / Munich GER
- Medical Research CouncilPost-Doctoral Researcher at Sir Gregory Winter's lab1995 — 1997Cambridge UK
- University of Vienna, Institute of BiochemistryScientific Team Leader & University Lecturer1993 — 1995Vienna AUT
Skills & more
+10 more
UnternehmertumTechnologietransferUnternehmensleitungDue DiligenceBusiness DevelopmentRisikokapitalLife SciencesRiskokapitalGeschäftsentwicklungStrategieLanguages Deutsch · Englisch · Spanisch
From Regina's professional profile.
Investments
Board seats
CarismaMinervaxNitec PharmaNovamedONWARDSeamlessSidekickSidekick HealthSNIPR BiomeStipeTRiCaresU3 Pharma
Investor
Atopix TherapeuticsBicycle TherapeuticsF-starJenavalveMiddle Peak MedicalOnwardRigontecSapiensSapiens MedicalThemisThemis Medical
Per the firm's website.
Colleagues at Angelini Ventures
Network1
Investors connected to Regina in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Regina Hodits?
- Regina Hodits is a Managing Director at Angelini Ventures. She previously served as Managing Partner at Wellington Partners Life Sciences and led the European life sciences efforts of Atlas Venture, and earlier worked at Apax Partners and McKinsey. She studied chemical engineering in Vienna, holds a Ph.D. in biochemistry, and conducted post-doctoral research at the MRC in Cambridge, UK.
- Where does Regina Hodits work?
- Regina Hodits is Managing Director at Angelini Ventures.
- What does Regina Hodits invest in?
- Regina Hodits invests in Biotech, Digital Health, Medical Devices.
- What boards does Regina Hodits sit on?
- Regina Hodits holds tracked board seats at Carisma, Minervax, Nitec Pharma, Novamed, ONWARD, Seamless, Sidekick, Sidekick Health, SNIPR Biome, Stipe.
- What companies has Regina Hodits invested in?
- Investments tracked here include Atopix Therapeutics, Bicycle Therapeutics, F-star, Jenavalve, Middle Peak Medical, Onward, Rigontec, Sapiens, Sapiens Medical, Themis, Themis Medical.
- Where did Regina Hodits go to school?
- Regina Hodits studied at Technische Universität Wien (Doctorate of Science / Biochemistry); McKinsey & Company Clearwater, USA (Executive MBA course); Technische Universität Wien (Masters of Science / Chemical Engineering).
Same school
Also attended Technische Universität Wien36
+ 30 more
Shared employers
Also worked at INiTS | Vienna's High-Tech Incubator2
Also worked at BioInnovation Institute13
+ 7 more
Also worked at EIT Health Germany1
Also worked at GSK GlaxoSmithKline137
+ 131 more

































